Trials / Terminated
TerminatedNCT03092154
Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The use of lipid lowering agents in patients with idiopathic inflammatory myopathies is controversial. Therefore, the aim of the present study is to assess clinically and laboratory the impact of lipid-lowering agents in this population.
Detailed description
Impact of the lipid lowering agents on patients with dermatomyositis and polymyositis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lipid-lowering agents (Artovastatin) | Artovastatin 20 mg /day, orally, 12 consecutive weeks. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2017-03-27
- Last updated
- 2022-06-03
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03092154. Inclusion in this directory is not an endorsement.